Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s

Posted in Research Highlights

Bio X Cell Reference Spotlight
Read More

Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression

Posted in Research Highlights

Bio X Cell Reference Spotlight
Read More

Immunocytokines are a promising immunotherapeutic approach against glioblastoma

Posted in Research Highlights

Bio X Cell Reference Spotlight
Read More

Macrophages on the Move: Visualization of Patrolling Alveolar Macrophages

Posted in Research Summary

More than 10,000 liters of non-sterile air pass through our lungs each day. Although most pathogens are filtered out in the upper respiratory tract, evidence suggests that some bacteria make their way into the alveoli where oxygen and carbon dioxide are exchanged in the lungs.
Read More

𝘐𝘯𝘝π˜ͺ𝘷𝘰MAb anti-human EphA2 (Clone B2D6)

Posted in New Products

Introducing 𝘐𝘯𝘝π˜ͺ𝘷𝘰MAb anti-human EphA2 Clone B2D6 for immunohistochemistry (paraffin), immunoprecipitation, and functional assay applications.
Read More

Endogenous DEL-1 restrains melanoma lung metastasis by limiting myeloid cell–associated lung inflammation

Posted in Research Highlights

Bio X Cell Reference Spotlight
Read More

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Posted in Research Highlights

Bio X Cell Reference Spotlight
Read More

π™„π™£π™‘π™žπ™«π™€MAb anti-human/monkey MDR-1 (CD243) (Clone UIC2)

The UIC2 monoclonal antibody reacts with an extracellular epitope of human and monkey (African Green) multidrug resistance protein 1 (MDR-1) also known as CD243, P-glycoprotein, and ABCB1. MDR-1 is a 170-180 kDa transmembrane glycoprotein that is expressed by epithelial and endothelial cells, and at low levels by T cells, B cells, NK cells, and hematopoietic stem cells. It is thought to be expressed at high levels by multidrug resistant (MDR) tumor cells. MDR-1 is as an ATP-dependent efflux pump for a large variety of molecules and drugs. This efflux activity has been suggested to lead to resistance to chemotherapy drugs. The UIC2 antibody has been reported to inhibit the efflux of MDR-1 substrates from MDR cells and increase the cytotoxicity of certain drugs in xenogeneic murine tumor models. The UIC2 antibody does not cross-react with mouse MDR-1.
Read More

STAT5 promotes accessibility and is required for BATF-mediated plasticity at the Il9 locus

Posted in Research Highlights

Bio X Cell Reference Spotlight
Read More

Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

Posted in Research Highlights

Bio X Cell Reference Spotlight
Read More